MuraliChintagumpalaMD

Pediatric Hematology & Oncology • Houston, TX

Professor, Pediatrics, Baylor College of Medicine

Join to view full profile

Dr. Chintagumpala is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chintagumpala's full profile

Already have an account?

Office
6701 Fannin St
Houston, TX 77030
Phone+1 832-822-4240

Fax+1 832-825-4247

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1988 - 1992
Columbus HospitalResidency, Pediatrics, 1985 - 1988
Madras Medical CollegeClass of 1982

Certifications & Licensure

TX State Medical License 1992 - 2025
IL State Medical License 1985 - 1993
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma Start of enrollment: 2004 Jul 01
Completed
Not Applicable
Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma Start of enrollment: 2005 Dec 01
Completed
Phase 3
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Start of enrollment: 2009 Feb 25
Completed
Phase 1
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Start of enrollment: 2010 Apr 19
Active, not recruiting
Phase 1, Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma Start of enrollment: 2013 Jun 23
Active, not recruiting
Phase 2
Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery Start of enrollment: 2014 Apr 01
Terminated
Phase 2
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors Start of enrollment: 2013 Aug 01
Completed
Phase 1
Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma Start of enrollment: 2014 Oct 31
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

A Case Series of Children With Medulloblastoma Depicting the Disparities in Care and the Challenges in the Detection and Treatment of Pediatric Central Nervous System ...
Victoria Katasi Mwebe, Emmanuel Wegoye, Julie Ssekabunga, Justine Onen, Solomon Kibudde
Pediatric Neurology. 2024-12-01
Letter to the editor in response to Tang et al.
Austin L Brown, Mohammad H Abu-Arja, Murali M Chintagumpala, Arnold C Paulino
Neuro-Oncology. 2024-11-04
2 citations
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.
Mohammad H Abu-Arja, Austin L Brown, Jack M Su, M Fatih Okcu, Holly B Lindsay
Neuro-Oncology. 2024-10-03

Other

Osteosarcoma: Epidemiology, pathogenesis, clinical presentation, diagnosis, and histology
Chintagumpala M, Wang LL, Gebhardt MC
http://www.uptodate.com/contents/osteosarcoma-epidemiology-pathogenesis-clinical-presentation-diagno
UpToDate, Wolters Kluwer Health - 2012-05-31
Presentation, diagnosis, and staging of Wilms tumor
Chintagumpala M, Muscal JA
http://www.uptodate.com/contents/presentation-diagnosis-and-staging-of-wilms-tumor
UpToDate, Wolters Kluwer Health - 2012-07-12
Treatment and prognosis of Wilms tumor
Chintagumpala M, Muscal JA
http://www.uptodate.com/contents/treatment-and-prognosis-of-wilms-tumor
UpToDate, Wolters Kluwer Health - 2013-02-19

MuraliChintagumpalaMD

Dr. Chintagumpala is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Viewing the full profile is available to verified healthcare professionals only.